Korea in the running to be global leader for biosimilars by 2017

Published: 2013-09-03 06:57:00
Updated: 2013-09-03 06:57:00
The Ministry of Food and Drug Safety (MFDS) unveiled a set of plans on Aug. 30 to nurture seven globally competitive biopharmaceutical companies by 2017.

The plans are intended to develop Korea into the seventh-largest power in the bioindustry.

Under the arrangement, the MFDS will approve a...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.